Landmark Capital acted as exclusive financial advisor of União Química Farmacêutica Nacional, one of Brazil´s biggest pharmaceutical companies, in the acquisition of a manufacturing site from Novartis, one of world´s biggest pharmaceuticals. This plant manufactures medicines to supply the Latin American market. Besides the acquisition of the asset, the transaction also included a long term manufacturing agreement of Novartis medicines by União Química. |
